SCHEMBL9060368

SCHEMBL9060368

NCC(O)C(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31074088 1.00 USP2 (0.50)
SCHEMBL23120067 1.00
SCHEMBL17047028 1.00
SCHEMBL17054062 1.00
SCHEMBL7211805 0.84 USP2 (0.58)
SCHEMBL6431831 0.84 USP2 (0.58)
SCHEMBL7211804 0.84 USP2 (0.58)
SCHEMBL14831444 0.80 GABRR1 (0.44)
SCHEMBL16751730 0.80 GABRR1 (0.44)
SCHEMBL14831445 0.80 GABRR1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4424821-A1 ENZYMATIC SYNTHESIS OF ODILORHABDIN AND RELATED PEPTIDES/PROTEINS COMPRISING NON-STANDARD AMINO ACID RESIDUES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2024-09-04 EP claimed
EP-4126923-A2 BARCODABLE EXCHANGEABLE PEPTIDE-MHC MULTIMER LIBRARIES Repertoire Immune Medicines, Inc. (US) 2023-02-08 EP claimed
EP-3110791-B1 PROCESS FOR PREPARING 2,4-DIAMINO-3-HYDROXYBUTYRIC ACID DERIVATIVES NOSOPHARM (FR) 2018-04-18 EP claimed
EP-2760881-B1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2017-11-01 EP claimed
US-9732049-B2 Process for preparing 2,4-diamino-3-hydroxybutyric acid derivatives NOSOPHARM (FR) 2017-08-15 US claimed
US-20170057936-A1 Process for Preparing 2,4-Diamino-3-Hydroxybutyric Acid Derivatives NOSOPHARM (FR) 2017-03-02 US claimed
US-9260481-B2 Peptide derivatives as antibiotics NOSOPHARM (FR) 2016-02-16 US claimed
US-20150175659-A1 Peptide Derivatives as Antibiotics INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2015-06-25 US claimed
EP-2760881-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS Nosopharm (FR) 2014-08-06 EP claimed
WO-2013045600-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2013-04-04 WO claimed
JP-8165271-A None JP disclosed
US-20250074945-A1 ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS UNIV UTAH RES FOUND (US) 2025-03-06 US disclosed
US-12215129-B2 Antibacterial cyclopeptides targeting acinetobacter and other gram-negative pathogens UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2025-02-04 US disclosed
US-20240401240-A1 METHODS AND SYSTEMS FOR ANALYSIS OF CHROMATIN 10X GENOMICS, INC. 2024-12-05 US disclosed
EP-4424821-A1 ENZYMATIC SYNTHESIS OF ODILORHABDIN AND RELATED PEPTIDES/PROTEINS COMPRISING NON-STANDARD AMINO ACID RESIDUES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2024-09-04 EP disclosed
US-9260481-B2 Peptide derivatives as antibiotics NOSOPHARM (FR) 2016-02-16 US disclosed
US-20150175659-A1 Peptide Derivatives as Antibiotics INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2015-06-25 US disclosed
EP-2760881-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS Nosopharm (FR) 2014-08-06 EP disclosed
WO-2013045600-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2013-04-04 WO disclosed
JP-H08165271-A PRODUCTION OF 2-HYDROXY-1,3-PROPANEDIAMINEPOLYCARBOXYLIC ACID, ITS ALKALI SALT AND BIODEGRADABLE CHELATE REAGENT CONTAINING THE SAME NITTO CHEM IND CO LTD 1996-06-25 JP disclosed